Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Posted on: Dec/23/2019 20:23:55
FDA approves $AGNs Ubrelvy (ubrogepant) for acute migraine treatment:
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152954071
Subscribe to Our Newsletter
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
Schedule a 30 minute Brand Awareness meeting with Market Wire News.
Schedule a MeetingLink your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.